FDA Inspection 1054722 — Bright Innovation Labs

Bright Innovation Labs — FEI 1000125317

The FDA completed an inspection of Bright Innovation Labs on June 7, 2018 in Santa Clarita, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 21 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 7, 2018
Fiscal Year
2018
Product Type
Food/Cosmetics
Project Area
Colors and Cosmetics Technology
Location
Santa Clarita, CA (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
145021 CFR 211.113(a)Procedures for non-sterile drug products
150521 CFR 211.122(d)Label storage access limited to authorized personnel
16495FDCA 601(c)Insanitary conditions; injurious to health
189021 CFR 211.165(e)Test methods
191421 CFR 211.166(a)Lack of written stability program
202721 CFR 211.192Investigations of discrepancies, failures
203121 CFR 211.194(a)Complete test data included in records
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
240221 CFR 211.194(a)(5)Testing Calculations
240521 CFR 211.194(a)(7)Identification of Person Performing the Testing
355321 CFR 211.48(a)Plumbing System Defects
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360221 CFR 211.160(a)Deviations from laboratory control requirements
361321 CFR 211.160(b)(4)Establishment of calibration procedures
430521 CFR 211.68(b)Backup data not assured as exact and complete
430921 CFR 211.84(c)(2)Containers sampled so as to prevent contamination
436021 CFR 211.170(b)Reserve drug product sample quantity - all tests
900121 CFR 211.22(a)Lack of quality control unit